drug
veligrotug
pre_registrationupdated 5mo agoby Viridian Therapeutics Inc
community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying veligrotug
News(1)
- Viridian data lift prospects for thyroid eye disease drugWhereas earlier Phase 3 results disappointed Wall Street, new findings in people with “chronic” disease were viewed by analysts as much more competitive with Amgen’s Tepezza.biopharma_dive · 5mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that